Presentation is loading. Please wait.

Presentation is loading. Please wait.

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume.

Similar presentations


Presentation on theme: "Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume."— Presentation transcript:

1 Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume 7, Issue 9, Pages (September 2008) DOI: /j.eursup Copyright © 2008 European Association of Urology Terms and Conditions

2 Fig. 1 Sunitinib expanded-access study: selected grade 3/4 treatment-related adverse events. PS, performance status. European Urology Supplements 2008 7, DOI: ( /j.eursup ) Copyright © 2008 European Association of Urology Terms and Conditions


Download ppt "Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume."

Similar presentations


Ads by Google